Abstract:Glutathione S-transferase Pi (GSTπ) is a marker protein in many cancers and high levels are linked to drug resistance, even when the selecting drug is not a substrate. S-Glutathionylation of proteins is critical to cellular stress response, but characteristics of the forward reaction are not known. Our results show that GSTπ potentiates S-glutathionylation reactions following oxidative and nitrosative stress in vitro and in vivo. Mutational analysis indicated that the catalytic activity of GST is required. GSTπ is itself redox-regulated. S-Glutathionylation on Cys47 and Cys101 autoregulates GSTπ, breaks ligand binding interactions with c-Jun NH2-terminal kinase (JNK), and causes GSTπ multimer formation, all critical to stress response. Catalysis of S-glutathionylation at low pK cysteines in proteins is a novel property for GSTπ and may be a cause for its abundance in tumors and cells resistant to a range of mechanistically unrelated anticancer drugs. Glutathione S-transferase Pi (GSTπ) is a marker protein in many cancers and high levels are linked to drug resistance, even when the selecting drug is not a substrate. S-Glutathionylation of proteins is critical to cellular stress response, but characteristics of the forward reaction are not known. Our results show that GSTπ potentiates S-glutathionylation reactions following oxidative and nitrosative stress in vitro and in vivo. Mutational analysis indicated that the catalytic activity of GST is required. GSTπ is itself redox-regulated. S-Glutathionylation on Cys47 and Cys101 autoregulates GSTπ, breaks ligand binding interactions with c-Jun NH2-terminal kinase (JNK), and causes GSTπ multimer formation, all critical to stress response. Catalysis of S-glutathionylation at low pK cysteines in proteins is a novel property for GSTπ and may be a cause for its abundance in tumors and cells resistant to a range of mechanistically unrelated anticancer drugs. Glutathione S-transferases (GSTs) 2The abbreviations used are: GST, glutathione S-transferase; JNK, c-Jun NH2-terminal kinase; MALDI-TOF, matrix-assisted laser desorption ionization time-of-flight; NO, nitric oxide; MEF, mouse embryo fibroblasts; HEK, human embryonic kidney; CDNB, 1-chloro-2,4-dinitrobenzene; PBS, phosphate-buffered saline; WT, wild type; CD, circular dichroism; PABA, O2-{2,4-dinitro-5-[4-(N-methylamino)benzoyloxy]phenyl}1-(N,N-dimethylamino)diazen-1-ium-1,2-diolate. are classified as a family of Phase II detoxification enzymes that have classically been described as catalyzing the conjugation of glutathione (GSH) to electrophilic compounds through thioether linkages (1Boyland E. Chasseaud L.F. Biochem. J. 1967; 104: 95-102Crossref PubMed Scopus (268) Google Scholar). The Pi class (GSTπ) is present at high levels in many solid tumors (particularly ovarian, non-small cell lung, breast, liver, pancreas, colon, and lymphomas) and has been indicated in many reports to be overexpressed in drug-resistant tumors (2Tew K.D. Cancer Res. 1994; 54: 4313-4320PubMed Google Scholar, 3Hayes J.D. Pulford D.J. Crit. Rev. Biochem. Mol. Biol. 1995; 30: 445-600Crossref PubMed Scopus (3254) Google Scholar). Although its increased expression was frequently linked with enhancement of drug detoxification, in most instances the selecting drugs were not substrates of GSTπ. This ambiguity and the high prevalence of GSTπ in tumors have intimated cellular functions for the protein that are unrelated to catalytic detoxification. Recently GSTπ has been identified as an endogenous protein binding partner and regulator of c-Jun NH2-terminal kinase (JNK) and peroxiredoxin VI (1-cysPrx) (4Adler V. Yin Z. Fuchs S.Y. Benezra M. Rosario L. Tew K.D. Pincus M.R. Sardana M. Henderson C.J. Wolf C.R. Davis R.J. Ronai Z. EMBO J. 1999; 18: 1321-1334Crossref PubMed Scopus (962) Google Scholar, 5Wang T. Arifoglu P. Ronai Z. Tew K.D. J. Biol. Chem. 2001; 276: 20999-21003Abstract Full Text Full Text PDF PubMed Scopus (272) Google Scholar, 6Manevich Y. Feinstein S.I. Fisher A.B. Proc. Natl. Acad. Sci. U. S. A. 2004; 101: 3780-3785Crossref PubMed Scopus (293) Google Scholar). Moreover, oxidative stress causes increased GSTπ expression, the regulation of which has been identified as a downstream event linked to wild-type p53 function (7Lo H.W. Pleasants L. Cao X. Milas M. Pollock R. Ali-Osman F. Mol. Cancer Res. 2008; 6: 848-850Crossref Scopus (44) Google Scholar). Cellular response to oxidative or nitrosative stress includes S-glutathionylation, a post-translational modification characterized by conjugation of glutathione to low pK cysteine sulfhydryl or sulfenic acid moieties in target proteins. This adds a three-amino acid side chain and introduces a net negative charge (as a consequence of glutamic acid) to the protein (8Shelton M.D. Chock P.B. Mieyal J.J. Antioxid. Redox Signal. 2005; 7: 348-366Crossref PubMed Scopus (326) Google Scholar). Consequently, protection from further oxidative damage and/or alteration of protein conformation affecting function and/or cellular localization occurs. Proteins so far identified that are susceptible to S-glutathionylation can be categorized into six distinct clusters: cytoskeletal, glycolysis/energy metabolism, kinases and signaling pathways, calcium homeostasis, antioxidant enzymes, and protein folding (9Mack J.T. Beljanski V. Soulika A.M. Townsend D.M. Brown C.B. Davis W. Tew K.D. Mol. Cell. Biol. 2007; 27: 44-53Crossref PubMed Scopus (33) Google Scholar). Reversibility of S-glutathionylation spontaneously by GSH or catalytically by glutaredoxin or sulfiredoxin (8Shelton M.D. Chock P.B. Mieyal J.J. Antioxid. Redox Signal. 2005; 7: 348-366Crossref PubMed Scopus (326) Google Scholar, 10Beer S.M. Taylor E.R. Brown S.E. Dahm C.C. Costa N.J. Runswick M.J. Murphy M.P. J. Biol. Chem. 2004; 279: 47939-47951Abstract Full Text Full Text PDF PubMed Scopus (347) Google Scholar) 3Findlay, V. J., Townsend, D. M., Morris, T. E., Fraser, J. P., He, L., and Tew, K. D. (2006) Cancer Res. 66, 6800–6806 provides the cell with a dynamic cycle of regulatory events. A plausible link between GSTπ and such regulation was provided by the observation that GSTπ could conjugate glutathione to a member of the peroxiredoxin family, peroxiredoxin VI, a non-selenoglutathione-dependent peroxidase that converts lipids and other hydroperoxides to corresponding alcohols (6Manevich Y. Feinstein S.I. Fisher A.B. Proc. Natl. Acad. Sci. U. S. A. 2004; 101: 3780-3785Crossref PubMed Scopus (293) Google Scholar, 12Ralat L.A. Manevich Y. Fisher A.B. Colman R.F. Biochemistry. 2006; 45: 360-372Crossref PubMed Scopus (158) Google Scholar). The catalytically important cysteine residue on peroxiredoxin VI is sterically inaccessible for GSH within the globular homodimeric complex and GSTπ facilitated transfer of GS- to this site. The resultant activation of the enzyme served a cellular regulatory role through maintaining intracellular H2O2 levels (13Rhee S.G. Science. 2006; 312: 1882-1883Crossref PubMed Scopus (1718) Google Scholar), particularly with respect to antioxidant protection of cell membranes. Moreover, S-glutathionylation of protein-tyrosine phosphatase (PTP1B) or protein-disulfide isomerase inactivates these enzymes and can have impact on kinase-mediated proliferative events and protein folding (14Townsend D.M. Findlay V.J. Fazilev F. Ogle M. Fraser J. Saavedra J.E. Ji X. Keefer L.K. Tew K.D. Mol. Pharmacol. 2006; 69: 501-508Crossref PubMed Scopus (89) Google Scholar, 15Townsend D.M. Mol. Interv. 2007; 7: 313-324Crossref PubMed Scopus (173) Google Scholar). 3Findlay, V. J., Townsend, D. M., Morris, T. E., Fraser, J. P., He, L., and Tew, K. D. (2006) Cancer Res. 66, 6800–6806 Both endogenous and exogenous reactive oxygen and nitrogen species generation can cause S-glutathionylation of certain targeted proteins. For the present studies, we developed multiple model systems of oxidative and nitrosative stress to investigate the role of GSTs in S-glutathionylation reactions, using oxidized glutathione (GSSG) and two agents, NOV-002 and PABA/NO. NOV-002 is a mimetic of oxidized glutathione and causes oxidative stress induction (16Townsend D.M. He L. Hutchens S. VandenBerg T.E. Pazoles C.J. Tew K.D. Cancer Res. 2008; 68: 2870-2877Crossref PubMed Scopus (73) Google Scholar). PABA/NO (O2-{2,4-dinitro-5-[4-(N-methylamino)benzoyloxy]phenyl}1-(N,N-dimethylamino)diazen-1-ium-1,2-diolate) (17Saavedra J.E. Srinivasan A. Buzard G.S. Davies K.M. Waterhouse D.J. Inami K. Wilde T.C. Citro M.L. Cuellar M. Deschamps J.R. Parrish D. Shami P.J. Findlay V.J. Townsend D.M. Tew K.D. Singh S. Jia L. Ji X. Keefer L.K. J. Med. Chem. 2006; 49: 1157-1164Crossref PubMed Scopus (81) Google Scholar) is a prodrug, which releases nitric oxide (NO) and activates stress response pathways that involve JNK, eventually leading to apoptosis (14Townsend D.M. Findlay V.J. Fazilev F. Ogle M. Fraser J. Saavedra J.E. Ji X. Keefer L.K. Tew K.D. Mol. Pharmacol. 2006; 69: 501-508Crossref PubMed Scopus (89) Google Scholar, 18Findlay V.J. Townsend D.M. Saavedra J.E. Buzard G.S. Citro M.L. Keefer L.K. Ji X. Tew K.D. Mol. Pharmacol. 2004; 65: 1070-1079Crossref PubMed Scopus (109) Google Scholar). Elevated levels of NO provide the primary source of reactive nitrogen species and can alter protein function directly through post-translational modifications (nitration/nitrosylation) or indirectly through interactions with oxygen, superoxide, thiols, and heavy metals, the products of which can lead to S-glutathionylation. Recognition that S-glutathionylation of proteins and its cycling is important in regulating critical cellular events means that there is a need to define both the forward and reverse components of the cycle. Until this time, the forward reaction of S-glutathionylation has been tacitly assumed to occur spontaneously. Our present study shows for the first time that GSTπ catalyzes protein S-glutathionylation in vivo and is contributory to its high expression levels in many drug-resistant tumors. Materials and Cell Lines—Generation of GSTπ wild-type and knock-out mice (19Henderson C.J. Smith A.G. Ure J. Brown K. Bacon E.J. Wolf C.R. Proc. Natl. Acad. Sci. U. S. A. 1998; 95: 5275-5280Crossref PubMed Scopus (348) Google Scholar), extraction of the mouse embryo fibroblasts (MEF) cells, and details of the transfected NIH3T3 cell lines were described previously (20Rosario L.A. O'Brien M.L. Henderson C.J. Wolf C.R. Tew K.D. Mol. Pharmacol. 2000; 58: 167-174Crossref PubMed Scopus (51) Google Scholar, 21Ruscoe J.E. Rosario L.A. Wang T. Gate L. Arifoglu P. Wolf C.R. Henderson C.J. Ronai Z. Tew K.D. J. Pharmacol. Exp. Ther. 2001; 298: 339-345PubMed Google Scholar). Cell lines were maintained in Dulbecco's modified Eagle's medium containing 10% fetal calf serum, 100 μg/ml streptomycin, 100 units/ml penicillin, and 2 mm l-glutamine at 5% CO2 and 37 °C. GSH (reduced) and GSSG (oxidized) were obtained from MP Biomedicals (Aurora, OH). PABA/NO was prepared as previously described (14Townsend D.M. Findlay V.J. Fazilev F. Ogle M. Fraser J. Saavedra J.E. Ji X. Keefer L.K. Tew K.D. Mol. Pharmacol. 2006; 69: 501-508Crossref PubMed Scopus (89) Google Scholar). NOV-002 was provided by Novelos Therapeutics, Inc. (Newton, MA). Human GSTπ Mutagenesis—Human GSTπ was amplified using PCR from a cDNA prepared from HEK293 cells using the following oligonucleotides: 5′-GCGCGAATTCATGCCGCCCTACACCGTGGT-3′ and 5′-GCGCAAGCTTTCACTGTTTCCCGTTGCCAT-3′. The resulting PCR fragments were cloned into the EcoRI/HindIII recognition sites of pCMV2b FLAG tag vector for mammalian expression and into the NheI/BamHI recognition sites of pET28b for expression in Escherichia coli. Cysteines 47 and 101 were changed to alanine by site-directed mutagenesis using the kit supplied by Stratagene (La Jolla, CA). The catalytically inactive mutant was generated by a single mutation (Y7F) by site-directed mutagenesis. The integrity of the inserts was confirmed by sequence analysis. Transfected Cell Lines—HEK293 cells were transfected with pCMV2b vector containing human wild-type (HEK293-WT), C47A mutation (HEK-Cys47), C101A mutation (HEK-Cys101), or the catalytically impaired mutant GSTπ (HEK-Y7F) using the transfection agent, Lipofectamine (Sigma). Mock transfectants (HEK-VA) were generated by transfecting HEK293 cells with the pCMV2b empty vector. GSTπ Activity Assays—The specific enzyme activity was evaluated with the 1-chloro-2,4-dinitrobenzene (CDNB) substrate as previously described (22Boyland E. Chasseaud L.F. Adv. Enzymol. Relat. Areas Mol. Biol. 1969; 32: 173-219PubMed Google Scholar). 48 h after transfection, HEK293 cells were lysed and 100 μg of protein per reaction assayed. The reaction mixture was carried out in 100 mm PBS with 1.0 mm EDTA, pH 6.5, containing 1 mm GSH and CDNB. The absorbance at 340 nm was monitored every 30 s for 2 min in a Bio-Rad Benchmark Plus Microplate Spectrophotometer. The rate of spontaneous conjugation of GSH to CDNB was subtracted from the rates of GSTπ-catalyzed reactions. The extinction coefficient (5.3 m-1 cm-1) for the CDNB conjugate at 340 nm in 96-well plates was used to calculate the specific activity. Protein Preparation—Cells (5 × 105 per treatment group) were collected and washed with PBS. Cell pellets were suspended in lysis buffer containing 20 mm Tris-HCl, pH 7.5, 15 mm NaCl, 1 mm EDTA, 1 mm EGTA, 1% Triton X-100, 2.5 mm sodium pyrophosphate, and 1 mm glycerophosphate with freshly added phosphatase inhibitors (5 mm sodium fluoride and 1 mm Na3VO4) and a protease inhibitor mixture (Sigma). Cells were incubated for 30 min on ice, disrupted by sonication (3 times for 10 s), and centrifuged for 30 min at 10,000 × g (4 °C). Protein concentrations in the supernatant were determined with the Bradford method (Bio-Rad) using IgG as a standard. Immunoblot Analysis—Equivalent amounts of protein were electrophoretically resolved under non-reducing conditions on 10% SDS-polyacrylamide gels; unmodified proteins were separated under reducing conditions. Proteins were transferred onto nitrocellulose membranes (Bio-Rad). Nonspecific binding was reduced by incubating the membrane in blocking buffer (20 mm Tris-HCl, pH 7.5, 150 mm NaCl, 0.1% Tween 20, 1 μm protease inhibitors, 5 mm sodium fluoride, and 1 mm Na3VO4) containing 10% nonfat dried milk for 1 h. Membranes were incubated with the indicated antibody (blocking buffer containing 5% nonfat dried milk) overnight at 4 °C, washed 3 times with PBS for 15 min, and incubated with the appropriate secondary antibody conjugated to horseradish peroxidase for 1 h. The membranes were washed 3 times and developed with enhanced chemiluminescence detection reagents (Bio-Rad). The blots were scanned with a Bio-Rad ChemiDoc system and visualized with a transilluminator. The images were stored in a TIFF format. The relative intensity of bands was evaluated using Quantity One software (version 4.5.2; Bio-Rad) and plotted as arbitrary units in relation to actin. An infrared excited dual color (red and green) fluorescent imaging system (Odyssey LI-COR, NE) was used to detect S-glutathionylation of GSTπ (GST-SSG) in HEK293 cells after treatment with increasing amounts of PABA/NO. Proteins from cell lysates were resolved electrophoretically and transferred to polyvinylidene difluoride membranes as described above. Membranes were treated with proprietary blocking buffer (LI-COR, NE) and incubated with both polyclonal anti-GSTπ (1:1,000 dilution, Medical & Biological Laboratories Co., Ltd. (MDL), Nagoya, Japan) and monoclonal anti-glutathionylated protein antibodies (1:1,000 dilution, Virogen, Watertown, MA) as described above. After washing 3 times with PBS an immunoblot was developed with anti-rabbit IRDye®800CW (green) and anti-mouse IRDye®680 (red) secondary antibodies simultaneously (1:1,000 dilution, both from LI-COR, NE) according to the manufacturer's protocol. Finally, immunoblots were imaged with Odyssey imaging system (LI-COR) and quantified with standard software (LI-COR, NE). In Vivo Models—GSTπ wild-type (GSTP1P2+/+) and knock-out (GSTP1P2-/-) mice (4 and 12 weeks old) were housed in the Animal Resource Facility of the Medical University of South Carolina. Animal care was provided in accordance with the procedures outlined in the Guide for the Care and Use of Laboratory Animals (NIH Publication 86-23, 1985). Animals were treated with 5 mg/kg PABA/NO or 25 mg/kg NOV-002 by tail vein injection. Blood was collected in heparin-coated tubes by orbital bleed at various time points. The liver was harvested and protein lysates were prepared and immediately assayed for cysteine modification. Identification of S-Glutathionylated Serum Proteins—100 μg of control and drug-treated serum was separated by two-dimensional SDS-PAGE under non-reducing conditions. Proteins were resuspended in 8 m urea with 0.5% carrier ampholytes and run on immobilized pH gradients covering exponentially the pH range from 3 to 10. For the second dimension, the immobilized pH gradient strips were separated on 10% polyacrylamide gels. Protein spots of interest were excised and subject to trypsin digestion. Peptide mass was analyzed by MALDI-TOF mass spectrometry at the Proteomics Core Facility of the Medical University of South Carolina. Protein identification was performed using software from the National Center for Biotechnology Information protein data base. Detection of Protein Sulfhydryls in Liver Homogenates of GSTπ+/+ and GSTπ-/- Mice—The supernatants of liver homogenate (100 μl) were passed through a BioSpin6 (Bio-Rad) micro-column to eliminate both GSH and GSSG. Then 20 μl of eluent was added to 2 ml of 40 mm PB, pH 7.4, in a quartz cuvette of PTI QM-8 spectrofluorometer (PTI Inc., Birmingham, NJ) under constant stirring at 37 °C. The emission (513 nm, excitation at 379 nm) of each sample was recorded for 1 min (background) before and 2 min after an addition of 5 μm (final concentration) ThioGlo-1 (Calbiochem). Each sample fluorescence saturation value corresponds to a concentration of free sulfhydryls. At the end of each experiment 1 μm reduced glutathione was added to the sample to ensure that saturation was not associated with the concentration of ThioGlo-1. The data represent mean ± S.E. (SigmaStat 10, SyStat, MA) of at least three independent measurements per condition. Spectroscopic Analysis of GSTπ in Vitro—The effect of GSTπ S-glutathionylation on enzyme secondary structure was examined by circular dichroism (CD) where measurements were carried out on a 202 AVIV Associates (Lakewood, NJ) using a semimicro quartz rectangular 1 × 10 × 40-mm cuvette. GSTπ samples (>95% homogeneous, 40 μm in 20 mm PB, pH 7.4) were maintained at 22 °C using a Pelletier element. Spectra were recorded while scanning in the far-ultraviolet region (190–260 nm), with bandwidth of 1.0 nm, step size of 1.0 nm, integration time of 30 s, and three repeats. The output of the CD spectrometer was recalculated according to the protein concentration, amino acid content, and cuvette thickness into molecular ellipticity units (degrees/cm2/dmol). Protein tryptophan fluorescence was recorded on an F2500 spectrofluorometer (Hitachi) using 10 × 10 × 40-mm quartz cuvette, excitation and emission slits were 2.5 and 5.0 nm, respectively. GSTπ samples (>95% homogeneous, 1.0 μm in 20 mm PB, pH 7.4) before and after treatment with PABA/NO and GSH were used. The excitation wavelength was 295 nm to minimize an effect of protein tyrosines and phenylalanines. Background spectra were subtracted from final emission of the protein. GSTπ (∼2 mg/ml) was S-glutathionylated by treatment with 25 μm PABA/NO and 1 mm GSH for 10 min in 40 mm PB, pH 7.4, at room temperature. Excess PABA/NO and GSH were eliminated by triplicate washing through Biospin-6 (Bio-Rad) SEC micro-spin columns with 20 mm PBS. Protein concentration was determined by the Bradford method (Bio-Rad). Data Analysis—Mean ± S.D. for at least three experiments were calculated for each treatment group. The immunoblots shown are representative of at least three essentially identical results. Data were analyzed for statistically significant differences between the control and experimental/treated groups with Student's paired t test using SigmaStat 3.5 (Systat Software Inc., MA). Impact of GSTπ Phenotype on Protein S-Glutathionylation following Oxidative and Nitrosative Stress—The physiological importance of S-glutathionylation is established and becomes critical to cellular stress responses (for review see Refs. 15Townsend D.M. Mol. Interv. 2007; 7: 313-324Crossref PubMed Scopus (173) Google Scholar). The mechanism of this reaction has not been defined as spontaneous or enzymatically catalyzed. In the first model system, MEF derived from GSTπ wild-type (GSTP1P2+/+) and null (GSTP1/P2-/-) mice were used to evaluate the dynamics of S-glutathionylation following exposure to agents that induce either oxidative (e.g. GSSG) or nitrosative stresses (e.g. PABA/NO). Using monoclonal antibodies directed toward the S-glutathionylated moiety (Virogen, Watertown, MA), we observed a time- (Fig. 1) and dose- (Fig. 2) dependent increase in protein modification (PSSG) following oxidative (GSSG) and nitrosative (PABA/NO) stress in MEF-GSTπ+/+ cells. Under basal conditions, S-glutathionylated proteins were essentially undetectable in either MEF-GSTπ+/+ or MEF-GSTπ-/- cells. The quantification of experimental data from 3 immunoblots was averaged and the exponential rise to maximal was statistically analyzed using SigmaStat. The dose dependence of PABA/NO-induced S-glutathionylation elicits a sigmoidal shape only for GSTπ+/+ indicative of an enzyme-controlled process (Fig. 2, panel C). The lag period may be explained by the accumulation of PABA/NO active metabolite(s). The time-dependent kinetics of PABA/NO-induced S-glutathionylation are described by similar bell-shaped curves for both GSTπ+/+ and GSTπ-/- cells (Fig. 1, panel C), perhaps corresponding to the dynamic, reversible origin of S-glutathionylation. The S-glutathionylation of cellular proteins in GSTπ+/+ cells is higher, starts earlier, and lasts longer when compared with the GSTπ-/- cells, p < 0.01. These data suggest that whereas basal levels of S-glutathionylation may be spontaneous or catalyzed by other GSTs, GSTπ contributes significantly to its facilitation and amplification. The dose dependence of GSSG-induced S-glutathionylation shows the expected rise-to-maximum shape indicative of a direct effect of this drug. The presence of GSTπ results in significant amplification of this effect (Fig. 2, panel C). The kinetics of GSSG-induced S-glutathionylation was similar to those for PABA/NO (Fig. 1, panel C). A major difference is that the shorter period of maximal basal S-glutathionylation may correspond to a direct effect of oxidant stress or a direct involvement of glutathione reductase.FIGURE 2GSTπ expression enhances dose-dependent S-glutathionylation of proteins. Mouse embryo fibroblast cells derived from GSTπ+/+ or GSTπ-/- animals were treated with various concentrations of GSSG (A) or PABA/NO (B) for 1 h. Proteins were resolved by non-reducing SDS-PAGE and S-glutathionylation evaluated by immunoblot (IB) with PSSG antibody (n = 4). The kinetics of the S-glutathionylation reaction were analyzed using a standard 2-parameter exponential rise to maximum fitting procedure (Sigma Plot 10, SyStat, MA) for dose dependence following GSSG or PABA/NO (C) for GSTπ+/+ (•) and GST-/- MEF (▴). Data represent mean ± variance; p < 0.01.View Large Image Figure ViewerDownload Hi-res image Download (PPT) Nitrosative stress induced by PABA/NO treatment leads to S-glutathionylation of multiple proteins, 10 of which were identified in a prior report (14Townsend D.M. Findlay V.J. Fazilev F. Ogle M. Fraser J. Saavedra J.E. Ji X. Keefer L.K. Tew K.D. Mol. Pharmacol. 2006; 69: 501-508Crossref PubMed Scopus (89) Google Scholar). Total protein S-glutathionylation (e.g. proteins ranging from ∼30 to ∼200 kDa) was quantitated following a 25 μm PABA/NO treatment where there were 7-fold more in MEF-GSTπ+/+ compared with GSTπ-/- cells (307 ± 72 versus 44 ± 6 arbitrary units, p < 0.01) (Fig. 2). Maximal PABA/NO-induced S-glutathionylation of proteins in MEF-GSTπ+/+ cells was evident at 30 min, whereas MEF-GSTπ-/- cells had no detectable levels of modified proteins at this time (Fig. 1). Oxidative stress induced by GSSG treatment produced a dose- and time-dependent S-glutathionylation of a single 42-kDa protein that we previously identified as actin (14Townsend D.M. Findlay V.J. Fazilev F. Ogle M. Fraser J. Saavedra J.E. Ji X. Keefer L.K. Tew K.D. Mol. Pharmacol. 2006; 69: 501-508Crossref PubMed Scopus (89) Google Scholar). Maximal S-glutathionylation of actin was detected at 300 μm GSSG (Fig. 2), was 1.8-fold higher in MEF-GSTπ+/+ (p < 0.01), and occurred maximally at 15 min compared with 1 h for MEF-GSTπ-/- cells. Individual globular actin (G-actin) subunits polymerize to form filamentous actin (F-actin). S-Glutathionylation of G-actin subunits prevents its polymerization, and decreases both stress fiber and focal contact formation. We examined the morphological effects of GSSG-induced S-glutathionylated actin in MEF-GSTπ+/+ or MEF-GSTπ-/- cells. Phalloidin staining shows that in MEF-GSTπ+/+ there is a decrease in formation of both stress fibers and focal contacts (Fig. 3) compared with MEF-GSTπ-/- cells. These morphological data are quite consistent with enhanced S-glutathionylation of cellular G-actin as a consequence of GSTπ. GSTπ-/- Mice Have Reduced Levels of an S-Glutathionylated Serum Protein, Contrapsin, following Drug Treatment—One- and three-month-old male GSTP1P2+/+ and GST1P2-/- mice were used as an in vivo model to evaluate GST-mediated S-glutathionylation of serum and liver proteins. Mice were treated with a single dose of either 5 mg/kg PABA/NO or 25 mg/kg NOV-002 (Fig. 4, panel A). NOV-002 treatment leads to enhanced S-glutathionylation of contrapsin in serum in a dose- and time-dependent manner. S-Glutathionylation of contrapsin was evaluated in serum 1 h following treatment. The averaged relative density of S-glutathionylated contrapsin bands (Fig. 4, panel B) following PABA/NO and NOV-002 treatment at 1 h was significantly higher in GSTP1P2+/+ mice compared with GSTP1P2-/- (n = 6, p < 0.01). Analysis of Cysteine Modification in Liver Tissue—The fluorescent probe, ThioGlo-1 specifically reacts with sulfhydryls (e.g. unmodified cysteine residues) and was used to assess hepatic proteins following PABA/NO and NOV-002 treatment in 3-month-old GSTP1P2+/+ and GST1P2-/- mice (Fig. 4, panel C). Reduced ThioGlo-1 emission corresponding with decreased protein sulfhydryl concentration (e.g. cysteine modification) was observed following PABA/NO and NOV-002 treatment in the liver homogenates of GSTP1P2+/+ mice (control, 16,152 ± 509; NOV-002, 15,155 ± 352; PABA/NO, 12,583 ± 476, p < 0.001). Protein sulfhydryl modification in the liver was greater for the PABA/NO-treated (∼22%) versus NOV-002-treated (∼6%) animals (n = 3, p < 0.001). These data are consistent with immunoblot analysis showing a large number of S-glutathionylated cellular proteins following PABA/NO treatment, whereas oxidized glutathione treatment led to S-glutathionylation of actin. However, no statistical differences were detected in the liver lysate from GSTP1P2-/- mice following treatment. Our data indicate that GSTπ expression quantitatively influences oxidative/nitrosative stress-mediated protein S-glutathionylation in vivo. The Enzymatic Activity of GSTπ Is Crucial for Protein S-Glutathionylation in Vivo—The third model system was designed to test if the enzymatic activity of GSTπ is required for S-glutathionylation reactions. HEK293 cells were transfected with either wild-type (HEK-WT) or a catalytically inactive mutant (23Dirr H. Reinemer P. Huber R. Eur. J. Biochem. 1994; 220: 645-661Crossref PubMed Scopus (387) Google Scholar) (HEK-Y7F) of GSTπ. To validate the model system, a general GST substrate (CDNB) was used to measure the specific activity (Table 1). Mock-transfected cells (HEK-VA) had GST specific activity of 59 ± 3 units/mg, whereas HEK-WT cells were significantly higher (75 ± 2 units/mg; p < 0.01). The specific activity of GST was significantly reduced in HEK-Y7F cells (12 ± 5 units/mg; p < 0.01), presumably as a consequence of a dominant negative effect (the catalytic activity of GST is attributed to the dimeric form). Residual activity can be attributed to other isoforms of GST present in HEK293 cells. This model system was then used to demonstrate that GSTπ activity caused the observed dose- and time-dependent increase in protein S-glutathionylation (Fig. 5). The dose-dependent studies demonstrated that at 15 μm PABA/NO, the amount of S-glutathionylated proteins following treatment was substantially higher in HEK-WT cells as compared with untreated controls (p < 0.05); whereas HEK-VA and HEK-Y7F were equivalent to untreated controls. The dose dependence of PABA/NO-induced S-glutathionylation in this model system (Fig. 5, panel C) shows similar kinetics as in MEF cells. The presence of enzymatically active GSTπ dramatically amplified S-glutathionylation. Temporal differences in S-glutathionylation patterns were also observed following a single dose of 50 μm PABA/NO (Fig. 5, panel B). Within 5 min, the relative levels of S-glutathionylation were saturated in HEK-WT cells (389 ± 12 arbitrary units, p < 0.001), whereas HEK-VA and HEK-Y7F cells were essentially equivalent to untreated controls (82 ± 9 and 63 ± 9 arbitrary units, p > 0.05). The HEK-Y7F cells (catalytically impaired GSTπ) had S-glutathionylation patterns that were below HEK-VA, suggesting a dominant negative effect. Kinetic differences of the HEK-293 model system (Fig. 5,

Abstract:Arachidonic acid (AA) and its metabolites play important roles in a variety of biological processes, such as signal transduction, contraction, chemotaxis, and cell proliferation and differentiation. It was demonstrated recently that AA can activate mitogen-activated protein kinases (MAPKs), which are crucial for transducing signals initiating cell growth and apoptosis. Here we studied the effect of AA on the induction of MAPK phosphatase-1 (MKP-1) in vascular smooth muscle cells (VSMCs) and found that AA stimulated induction of MKP-1 mRNA and proteins in VSMCs in a time- and dose-dependent manner. Specific inhibitors of cyclooxygenase-, lipoxygenase-, and cytochrome P450-dependent metabolism did not affect AA-induced MKP-1 expression, indicating that eicosanoid biosynthesis was not involved in this process. The glutathione precursor N-acetylcysteine, an antioxidant, abolished AA-stimulated MKP-1 gene expression, whereas inhibition of protein kinase C by calphostin C had no influence on MKP-1 induction. VSMC pretreatment with genistein, a tyrosine kinase inhibitor, completely blocked AA-stimulated MKP-1 induction. MAPK kinase inhibitor PD 98059 did abolish AA-stimulated activation of extracellular signal-regulated kinases but not MKP-1 induction. Furthermore, agonists that increase AA release stimulated MKP-1 induction and activation of MAPKs, including extracellular signal-regulated kinases and c-Jun NH2-terminal protein kinases or stress-activated protein kinases. Taken together, our findings demonstrate that AA induced MKP-1 expression in VSMCs via activation of tyrosine kinases involving AA-induced free radical generation, suggesting an important role for MKP-1 in the regulation of AA-initiated signal transduction in VSMCs. Arachidonic acid (AA) and its metabolites play important roles in a variety of biological processes, such as signal transduction, contraction, chemotaxis, and cell proliferation and differentiation. It was demonstrated recently that AA can activate mitogen-activated protein kinases (MAPKs), which are crucial for transducing signals initiating cell growth and apoptosis. Here we studied the effect of AA on the induction of MAPK phosphatase-1 (MKP-1) in vascular smooth muscle cells (VSMCs) and found that AA stimulated induction of MKP-1 mRNA and proteins in VSMCs in a time- and dose-dependent manner. Specific inhibitors of cyclooxygenase-, lipoxygenase-, and cytochrome P450-dependent metabolism did not affect AA-induced MKP-1 expression, indicating that eicosanoid biosynthesis was not involved in this process. The glutathione precursor N-acetylcysteine, an antioxidant, abolished AA-stimulated MKP-1 gene expression, whereas inhibition of protein kinase C by calphostin C had no influence on MKP-1 induction. VSMC pretreatment with genistein, a tyrosine kinase inhibitor, completely blocked AA-stimulated MKP-1 induction. MAPK kinase inhibitor PD 98059 did abolish AA-stimulated activation of extracellular signal-regulated kinases but not MKP-1 induction. Furthermore, agonists that increase AA release stimulated MKP-1 induction and activation of MAPKs, including extracellular signal-regulated kinases and c-Jun NH2-terminal protein kinases or stress-activated protein kinases. Taken together, our findings demonstrate that AA induced MKP-1 expression in VSMCs via activation of tyrosine kinases involving AA-induced free radical generation, suggesting an important role for MKP-1 in the regulation of AA-initiated signal transduction in VSMCs. Mitogen-activated protein kinases (MAPKs), 1The abbreviations used are: MAPK(s), mitogen-activated protein kinase; AA, arachidonic acid; ERK, extracellular signal-regulated kinase; GST, glutathioneS-transferase; JNK, c-Jun NH2-terminal protein kinase; MKP, mitogen-activated protein kinase phosphatase; MOPS, 4-morpholinepropanesulfonic acid; PDGF, platelet-derived growth factor; PKC, protein kinase C; PMA, phorbol 12-myristate 13-acetate; SAPK, stress-activated protein kinase; VSMC, vascular smooth muscle cell. 1The abbreviations used are: MAPK(s), mitogen-activated protein kinase; AA, arachidonic acid; ERK, extracellular signal-regulated kinase; GST, glutathioneS-transferase; JNK, c-Jun NH2-terminal protein kinase; MKP, mitogen-activated protein kinase phosphatase; MOPS, 4-morpholinepropanesulfonic acid; PDGF, platelet-derived growth factor; PKC, protein kinase C; PMA, phorbol 12-myristate 13-acetate; SAPK, stress-activated protein kinase; VSMC, vascular smooth muscle cell. a ubiquitous group of serine/threonine kinases, are thought to play a crucial role in transmitting transmembrane signals required for cell growth, differentiation, and apoptosis (1Nishida E. Gotoh Y. Trends Biochem. Sci. 1993; 18: 128-131Abstract Full Text PDF PubMed Scopus (959) Google Scholar, 2Ruderman J.V. Curr. Opin. Cell Biol. 1993; 5: 207-213Crossref PubMed Scopus (118) Google Scholar, 3Seger R. Krebs E.G. FASEB J. 1995; 9: 726-735Crossref PubMed Scopus (3192) Google Scholar). At least three distinct subfamilies of MAPK exist: extracellular signal-regulated kinases (ERKs), c-Jun NH2-terminal protein kinases (JNKs) or stress-activated protein kinases (SAPKs), and p38 MAPKs (1Nishida E. Gotoh Y. Trends Biochem. Sci. 1993; 18: 128-131Abstract Full Text PDF PubMed Scopus (959) Google Scholar, 2Ruderman J.V. Curr. Opin. Cell Biol. 1993; 5: 207-213Crossref PubMed Scopus (118) Google Scholar, 3Seger R. Krebs E.G. FASEB J. 1995; 9: 726-735Crossref PubMed Scopus (3192) Google Scholar, 4Cano E. Mahadevan L.C. Trends Biochem. Sci. 1995; 20: 117-122Abstract Full Text PDF PubMed Scopus (997) Google Scholar, 5Dérijard B. Hibi M. Wu I.-H. Barrett T. Su B. Deng T. Karin M. Davis R.J. Cell. 1994; 76: 1025-1037Abstract Full Text PDF PubMed Scopus (2953) Google Scholar, 6Kyriakis J.M. Banerjee P. Nikolakaki E. Dai T. Rubie E.A. Ahmad M.F. Avruch J. Woodgett J.R. Nature. 1994; 369: 156-160Crossref PubMed Scopus (2411) Google Scholar, 7Davis R.J. J. Biol. Chem. 1993; 268: 14553-14556Abstract Full Text PDF PubMed Google Scholar). The ERKs, SAPKs, and p38 MAPKs are activated by the reversible dual threonine and tyrosine phosphorylation of a conserved TEY, TPY, or TGY motif, respectively (6Kyriakis J.M. Banerjee P. Nikolakaki E. Dai T. Rubie E.A. Ahmad M.F. Avruch J. Woodgett J.R. Nature. 1994; 369: 156-160Crossref PubMed Scopus (2411) Google Scholar, 7Davis R.J. J. Biol. Chem. 1993; 268: 14553-14556Abstract Full Text PDF PubMed Google Scholar, 8Cobb M.H. Goldsmith E.J. J. Biol. Chem. 1995; 270: 14843-14846Crossref PubMed Scopus (1659) Google Scholar, 9Sanchez I. Hughes R.T. Mayer B.J. Yee K. Woodgett J.R. Avruch J. Kyriakis J.M. Zon L.I. Nature. 1994; 372: 794-798Crossref PubMed Scopus (916) Google Scholar). Although distinct and selective MAPK activators have been cloned and characterized (1Nishida E. Gotoh Y. Trends Biochem. Sci. 1993; 18: 128-131Abstract Full Text PDF PubMed Scopus (959) Google Scholar, 2Ruderman J.V. Curr. Opin. Cell Biol. 1993; 5: 207-213Crossref PubMed Scopus (118) Google Scholar, 3Seger R. Krebs E.G. FASEB J. 1995; 9: 726-735Crossref PubMed Scopus (3192) Google Scholar, 4Cano E. Mahadevan L.C. Trends Biochem. Sci. 1995; 20: 117-122Abstract Full Text PDF PubMed Scopus (997) Google Scholar, 5Dérijard B. Hibi M. Wu I.-H. Barrett T. Su B. Deng T. Karin M. Davis R.J. Cell. 1994; 76: 1025-1037Abstract Full Text PDF PubMed Scopus (2953) Google Scholar, 6Kyriakis J.M. Banerjee P. Nikolakaki E. Dai T. Rubie E.A. Ahmad M.F. Avruch J. Woodgett J.R. Nature. 1994; 369: 156-160Crossref PubMed Scopus (2411) Google Scholar, 7Davis R.J. J. Biol. Chem. 1993; 268: 14553-14556Abstract Full Text PDF PubMed Google Scholar), less is known about negative regulation of these kinases. Several protein phosphatases with high specificity for MAPKs have been described, including the ubiquitously expressed rodent MAPK phosphatase-1 (MKP-1), its human homolog CL100, and the lymphocyte-specific PAC-1 protein (10Sun H. Charles C.H. Lau L.F. Tonks N.K. Cell. 1993; 75: 487-493Abstract Full Text PDF PubMed Scopus (1023) Google Scholar, 11Charles C.H. Sun H. Lau L.F. Tonks N.K. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 5292-5296Crossref PubMed Scopus (183) Google Scholar, 12Ward Y. Gupta S. Jensen P. Wartmann M. Davis R.J. Kelly K. Nature. 1994; 367: 651-654Crossref PubMed Scopus (295) Google Scholar, 13Alessi D.R. Smythe C. Keyse S.M. Oncogene. 1993; 8: 2015-2020PubMed Google Scholar, 14Liu Y. Gorospe M. Yang C. Holbrook N.J. J. Biol. Chem. 1995; 270: 8377-8380Crossref PubMed Scopus (285) Google Scholar). A number of studies have implicated MKP-1 in the regulation of mitogenesis (10Sun H. Charles C.H. Lau L.F. Tonks N.K. Cell. 1993; 75: 487-493Abstract Full Text PDF PubMed Scopus (1023) Google Scholar, 14Liu Y. Gorospe M. Yang C. Holbrook N.J. J. Biol. Chem. 1995; 270: 8377-8380Crossref PubMed Scopus (285) Google Scholar). MKP-1 has been shown to dephosphorylate phosphothreonine and phosphotyrosine residues of both ERKs and SAPKs, resulting in their inactivation, although it exhibits cell type specificity (10Sun H. Charles C.H. Lau L.F. Tonks N.K. Cell. 1993; 75: 487-493Abstract Full Text PDF PubMed Scopus (1023) Google Scholar, 11Charles C.H. Sun H. Lau L.F. Tonks N.K. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 5292-5296Crossref PubMed Scopus (183) Google Scholar, 12Ward Y. Gupta S. Jensen P. Wartmann M. Davis R.J. Kelly K. Nature. 1994; 367: 651-654Crossref PubMed Scopus (295) Google Scholar, 13Alessi D.R. Smythe C. Keyse S.M. Oncogene. 1993; 8: 2015-2020PubMed Google Scholar, 14Liu Y. Gorospe M. Yang C. Holbrook N.J. J. Biol. Chem. 1995; 270: 8377-8380Crossref PubMed Scopus (285) Google Scholar). Thus, the balance between MAPK activation and MKP-1 induction should be an important point in determining the fate of cells stimulated by environmental insults. Arachidonic acid (AA) and its metabolites are critical to a variety of biological processes, such as chemotaxis, inflammation, and signal transduction (15Hanahan D.J. Annu. Rev. Biochem. 1986; 55: 483-509Crossref PubMed Google Scholar, 16Axelrod J. Burch R.M. Jelsema C.L. Trends Neurosci. 1988; 11: 117-123Abstract Full Text PDF PubMed Scopus (428) Google Scholar). In addition to these functions, several investigators in recent years have reported that some peptide growth factors such as epidermal growth factor and fibroblast growth factors stimulate AA production in a number of cell types (17Peppelenbosch M.P. Tertoolen L.G. den Hertog J. deLaat S.W. Cell. 1992; 69: 295-303Abstract Full Text PDF PubMed Scopus (158) Google Scholar, 18Handler J.A. Danilowicz R.M. Eling T.E. J. Biol. Chem. 1990; 265: 3669-3673Abstract Full Text PDF PubMed Google Scholar, 19Sellmayer A. Uedelhoven W.M. Weber P.C. Bonventre J.V. J. Biol. Chem. 1991; 266: 3800-3807Abstract Full Text PDF PubMed Google Scholar, 20Fafeur V. Jiang Z.P. Bohlen P. J. Cell. Physiol. 1991; 149: 277-283Crossref PubMed Scopus (47) Google Scholar). In fact, it was also found that induction of mitogenesis by these growth factors required AA metabolism (18Handler J.A. Danilowicz R.M. Eling T.E. J. Biol. Chem. 1990; 265: 3669-3673Abstract Full Text PDF PubMed Google Scholar, 19Sellmayer A. Uedelhoven W.M. Weber P.C. Bonventre J.V. J. Biol. Chem. 1991; 266: 3800-3807Abstract Full Text PDF PubMed Google Scholar, 20Fafeur V. Jiang Z.P. Bohlen P. J. Cell. Physiol. 1991; 149: 277-283Crossref PubMed Scopus (47) Google Scholar). AA metabolites have been found to stimulate growth in many cell types, including vascular smooth muscle cells (VSMCs) when added exogenously (21Owen N.E. Am. J. Physiol. 1986; 250: C584-C588Crossref PubMed Google Scholar, 22Palmberg L. Claesson H.E. Thyberg J. J. Cell Sci. 1987; 88: 151-159PubMed Google Scholar, 23Setty B.N.Y. Graeber J.E. Stuart M.J. J. Biol. Chem. 1987; 262: 17613-17622Abstract Full Text PDF PubMed Google Scholar, 24Harris R.C. Homma T. Jacobson H.R. Capdevila J. J. Cell. Physiol. 1990; 144: 429-437Crossref PubMed Scopus (91) Google Scholar). Recently, it was demonstrated that AA activates both ERKs and JNKs/SAPKs in VSMCs or epithelial cells (25Rao G.N. Baas A.S. Glasgow W.C. Eling T.E. Runge M.S. Alexander R.W. J. Biol. Chem. 1994; 269: 32586-32591Abstract Full Text PDF PubMed Google Scholar, 26Hii C.S.T. Ferrante A. Edwards Y.S. Huang Z.H. Hartfield P.J. Rathjen D.A. Poulos A. Murray A.W. J. Biol. Chem. 1995; 270: 4201-4204Abstract Full Text Full Text PDF PubMed Scopus (106) Google Scholar, 27Cui X.L. Douglas J.G. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 3771-3776Crossref PubMed Scopus (163) Google Scholar), indicating an important role for AA and its metabolites in mitogenic signaling events. However, no data exist as to whether AA induces MKP-1 expression, which is important in regulating MAPK activity during cell proliferation. In the present study, we evaluated the potential effects of AA on MKP-1 induction in VSMCs using Western and Northern blot analyses and demonstrated that AA stimulation results in MKP-1 mRNA expression followed by increased protein induction. The mechanism appears to involve AA-stimulated superoxide generation, which activates tyrosine kinases and is independent of downstream eicosanoid biosynthesis and of protein kinase C (PKC) signal pathways. A rat MKP-1 cDNA was isolated from rat lung cDNA library by Liu et al. (14Liu Y. Gorospe M. Yang C. Holbrook N.J. J. Biol. Chem. 1995; 270: 8377-8380Crossref PubMed Scopus (285) Google Scholar). Plasmids expressing MKP-1 were propagated in Escherichia coli, and cDNA was obtained by cutting the plasmids with EcoRI. Polyclonal antibodies against rat MKP-1, mammalian ERK2, and JNK1/SAPK were obtained from Santa Cruz Biochemicals (Santa Cruz, CA). The monoclonal antibody against phosphorylated ERK1/2 was obtained from New England Biolabs, Inc. (Beverly, MA). Arachidonic acid, linoleic acid, stearic acid (tissue culture grade), calphostin C, phorbol 12-myristate 13-acetate (PMA), cinnamyl-3,4-dihydroxy-a-cyanocinnamate, and ketoconazole were obtained from BIOMOL Research Laboratories, Inc. (Plymouth Meeting, PA). Genistein, herbimycin A, andN-acetylcysteine were from Calbiochem-Novaniochem International (La Jolla, CA). H2O2 was purchased from E. Merck, Darmstadt, Germany. Indomethacin, angiotensin II, endothelin-1, bradykinin, and platelet-derived growth factor (PDGF)-AB were purchased from Sigma and PD 98059 from AlexisTM Biochemicals (Läufelfingen, Switzerland). VSMCs were isolated by enzymatic digestion of rat aortas according to the procedure of Ross and Kariya (28Ross R. Kariya B. Bohr D.F. Somlyo A.P. Sparks H.V. Handbook of Physiology: Circulation, Vascular Smooth Muscle. American Physiological Society, Bethesda, MD1980: 69-91Google Scholar) with a slight modification (29Xu Q. Li D. Holbrook N.J. Udelsman R. Circulation. 1995; 92: 1223-1229Crossref PubMed Scopus (101) Google Scholar) and cultured in medium RPMI 1640 (Life Technologies, Inc.) supplemented with 20% fetal calf serum, penicillin (100 units/ml), and streptomycin (100 μg/ml). Cells were incubated at 37 °C in a humidified atmosphere of 5% CO2 in air. The medium was changed every 3 days, and cells were passaged by treatment with a solution of 0.05% trypsin and 0.02% EDTA. Experiments were conducted on VSMCs that had just achieved confluence. VSMCs were serum starved for 4 days and incubated with AA in the presence or absence of inhibitors at 37 °C for the times indicated in figure legends. After two washes with cold (4 °C) phosphate-buffered saline, pH 7.4, cells were harvested on ice in buffer A containing 20 mm Hepes, pH 7.4, 2 mm EDTA, 1 mmβ-glycerophosphate, 1 mm dithiothreitol, 1 mmNa3VO4, 1% Triton, 10% glycerol, 1 μg/ml leupeptin, 1 μg/ml aprotinin, 400 μmphenylmethylsulfonyl fluoride. The suspension was incubated on ice for 20 min with vortexing every 5 min. Cellular debris were then pelleted by centrifugation for 30 min at 13,000 rpm (Eppendorf centrifuge, Osterode, Germany) at 4 °C, supernatants collected, and protein concentration measured by the Bio-Rad assay. Fifty μg of total VSMC proteins was separated by electrophoresis through a 10% SDS-polyacrylamide gel and transferred onto nitrocellulose membranes (BA85; Schleicher and Schuell, Dassel, Germany). After blocking with 5% nonfat dry milk (Sigma) for 1 h, the blots were probed with affinity-purified polyclonal antibodies against MKP-1 (1 μg/ml in phosphate-buffered saline containing 5% nonfat dry milk) or monoclonal antibodies against phosphorylated ERK1/2 for 2 h. The reaction was visualized using horseradish peroxidase-conjugated swine anti-rabbit or rabbit anti-mouse antibodies (Dako, Copenhagen, Denmark) at a 1:3,000 dilution. After two washes with phosphate-buffered saline, specific antibody-antigen complexes were detected using the ECL Western blot Detection Kit (Amersham Corp., Buckinghamshire, UK) as described previously (30Xu Q. Hu Y. Kleindienst R. Wick G. J. Clin. Invest. 1997; 100: 1089-1097Crossref PubMed Scopus (127) Google Scholar). Graphs of the blots were obtained in the linear range of detection and were quantified for the levels of specific induction or blocking by scanning laser densitometry (Power-Look II, UMAX Data System Inc., Hsinchu, Taiwan) of graphs. Total RNA (10 μg/lane) was isolated, denaturated with formaldehyde (Merck), electrophoresed in a 1% agarose gel, transferred onto a nylon membrane (Zeta Probe; Bio-Rad), and UV cross-linked in a UV Stratalinker (Stratagene Inc., La Jolla, CA). Hybridizations were performed using a fluorescein-labeled (Amersham Corp.) cDNA probe for MKP-1, as described previously (31Xu Q. Fawcett T.W. Gorospe M. Guyton K.Z. Liu Y. Holbrook N.J. Hypertension. 1997; 30: 106-111Crossref PubMed Scopus (32) Google Scholar). The membranes were then washed, detected with anti-fluorescein alkaline phosphatase conjugate (1:5,000) (Amersham Corp.), and exposed to ECL films (Amersham Corp.). Graphs of the blots were obtained in the linear range of detection. Accuracy of loading and transfer as well RNA integrity were confirmed by quantitative analysis of the 28 S and 18 S RNA. VSMCs were serum starved for 4 days, stimulated with AA, and harvested with buffer A. The cell suspension was incubated on ice for 15 min and centrifuged at 13,000 rpm for 30 min. The supernatant was harvested and protein concentration measured with Bio-Rad protein assay reagent (Bio-Rad). Protein A-Sepharose 4B suspension (Sigma) was added to the supernatant (100 μl/ml) and rotated for 2 h at 4 °C. After centrifugation at 13,000 rpm for 10 min, the supernatant was harvested. For kinase assays, 0.5 ml of the supernatant containing 0.5 mg of proteins was incubated with 10 μl of antibodies against mammalian ERK2 or JNK1/SAPK for 2 h at 4 °C with rotation. These antibodies have been shown to recognize specifically mammalian ERK2p42 and JNK1p54. Subsequently, 40 μl of protein A-Sepharose 4B suspension was added, and rotation continued for 1 h at 4 °C. Immunocomplexes were precipitated by centrifugation and washed twice with buffers A, B (500 mm LiCl, 100 mm Tris, 1 mmdithiothreitol, 0.1% Triton X-100, pH 7.6), and C (20 mmMOPS, 2 mm EGTA, 10 mm MgCl2, 1 mm dithiothreitol, 0.1% Triton X-100, pH 7.2), respectively. ERK2 activities in the immunocomplexes were measured as described previously (32Xu Q. Liu Y. Gorospe M. Udelsman R. Holbrook N.J. J. Clin. Invest. 1996; 97: 508-514Crossref PubMed Scopus (184) Google Scholar, 33Liu Y. Guyton K.Z. Gorospe M. Xu Q. Kokkonen G.C. Mock Y.D. Roth G.S. Holbrook N.J. J. Biol. Chem. 1996; 271: 3604-3607Abstract Full Text Full Text PDF PubMed Scopus (102) Google Scholar, 34Hu Y. Cheng L. Hochleitner B.W. Xu Q. Arterioscler. Thromb. Vasc. Biol. 1997; 17: 2808-2816Crossref PubMed Scopus (154) Google Scholar). Briefly, immunocomplexes were incubated with 35 μl of buffer C supplemented with 6 μg of myelin basic protein (Upstate Biotechnology, Inc., Lake Placid, NY), 5 μCi of [γ-32P]ATP, 50 mm MgCl2, and 30 μm ATP for 20 min at 37 °C with vortexing every 3 min. To stop the reaction, 15 μl of 4 × Laemmli buffer was added, and the mixture was boiled for 5 min. Proteins in the kinase reaction were resolved by SDS-polyacrylamide gel electrophoresis (15% gel) and subjected to autoradiography. The assay for JNK/SAPK activity was performed as described above using GST-c-Jun as substrate (the plasmid was provided by Dr. J. Woodgett) produced in E. coli and isolated using glutathione-Sepharose 4B RediPack Columns (Pharmacia Biotech Inc., Piscataway, NJ) per the manufacturer's protocol. Proteins in the kinase reaction were resolved by SDS-polyacrylamide gel electrophoresis (12% gel) and subjected to autoradiography (6Kyriakis J.M. Banerjee P. Nikolakaki E. Dai T. Rubie E.A. Ahmad M.F. Avruch J. Woodgett J.R. Nature. 1994; 369: 156-160Crossref PubMed Scopus (2411) Google Scholar, 35Hu Y. Metzler B. Xu Q. J. Biol. Chem. 1997; 272: 9113-9119Abstract Full Text Full Text PDF PubMed Scopus (60) Google Scholar). Analysis of variance was performed when more than two groups were compared. An unpaired Student'st test was used to assess differences between two groups. Ap value less than 0.05 was considered significant. Growth-arrested VSMCs were exposed to 20 μm AA for varying times, and protein extracts were prepared. Equal amounts of proteins from control and experimental samples were used to test MKP-1 induction using Western blot analysis. As shown in Fig.1 A, exposure of cells to AA resulted in a time-dependent induction of MKP-1 which was evident at 20 min, peaked at 1 h, and declined thereafter. Fig.1 B summarizes MKP-1 induction as determined by quantification of optical densities from autoradiograms of three experiments. Exposure of cells to AA produced 10–20-fold changes in MKP-1 after 1 or 2 h in protein extracts of VSMCs. AA-stimulated MKP-1 induction was also dose-dependent in that an increment in the proteins was observed at 2 μm and was maximal at 20 μm (Fig. 1 C). In addition, other fatty acids, including linoleic acid and stearic acid, did not significantly stimulate MKP-1 induction (data not shown). MKP-1 mRNA levels in AA-treated VSMCs were analyzed by Northern blots. As shown in Fig. 2, AA treatment resulted in significantly increased MKP-1 mRNA in VSMCs. Kinetic analysis of the response revealed that AA-induced MKP-1 mRNA expression occurred as early as 20 min (Fig. 2 A), with maximum levels (10-fold greater than untreated control) achieved between 20 min and 1 h after treatment and a return to basal levels thereafter. To establish further the relationship between AA treatment and MKP-1 expression, we performed a dose-response analysis of AA-induced MKP-1 mRNA accumulation. As shown in Fig.2 B, MKP-1 mRNA levels increased in a dose-dependent manner between 3 and 80 μm. The lower halves of Fig. 2 (Aand B) show the amount of 28 S and 18 S RNA from the corresponding blot. In most mammalian cells, AA is oxidized through the cyclooxygenase and/or cytochrome P450 pathways to yield eicosanoids that mediate biological effects. To evaluate the contributions of these metabolic pathways, VSMCs were treated with the cyclooxygenase inhibitor indomethacin, the lipoxygenase inhibitor cinnamyl-3,4-dihydroxy-a-cyanocinnamate, or the cytochrome P450 inhibitor ketoconazole for 30 min followed by stimulation with 20 μm AA. Indomethacin (20 μm) effectively inhibited 6-keto prostaglandin F1α production stimulated by exogenous AA in VSMCs (data not shown) and did not significantly stimulate MKP-1 induction (Fig.3, upper panel). Two other inhibitors did not stimulate MKP-1 production at doses known to abrogate eicosanoid biosynthesis in mammalian cells (36Civan M.M. Coca-Prados M. Peterson-Yantorno K. Invest. Opthalmol. Vis. Sci. 1994; 35: 2876-2886PubMed Google Scholar, 37Hata Y. Ota S. Nagata T. Uehara Y. Terano A. Sugimoto T. Prostaglandins. 1993; 45: 129-141Crossref PubMed Scopus (20) Google Scholar, 38Capdevila J. Gil L. Orellana M. Marnett L.J. Mason J.I. Yadagiri P. Falck J.R. Arch. Biochem. Biophys. 1988; 261: 257-263Crossref PubMed Scopus (168) Google Scholar) (Fig. 3). These inhibitors did not block the MKP-1 induction in AA-stimulated VSMCs but moderately enhanced this induction (Fig. 3). There is evidence that ketoconazole could effectively block ERK activation and calcium mobilization, but not JNK/SAPK activation, after AA stimulation (27Cui X.L. Douglas J.G. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 3771-3776Crossref PubMed Scopus (163) Google Scholar, 39Madhun Z.T. Goldthwait D.A. McKay D. Hopfer U. Douglas J.G. J. Clin. Invest. 1991; 88: 456-461Crossref PubMed Scopus (117) Google Scholar). Thus, our findings suggested that AA-stimulated MKP-1 induction in VSMCs did not require subsequent eicosanoid biosynthesis. Early studies demonstrated that AA activates PKC (40Kikkawa U. Ogita K. Shearman M.S. Ase K. Sekiguchi K. Naor Z. Ido M. Nishizuka Y. Saito N. Tanaka C. Ono Y. Fujii T. Igarashi K. Philos. Trans. R. Soc. Lond.-Biol. Sci. 1988; 320: 313-324Crossref PubMed Scopus (22) Google Scholar, 41Dell K.R. Severson D.L. Biochem. J. 1989; 258: 171-175Crossref PubMed Scopus (25) Google Scholar), and the PKC agonists PMA induces MKP-1 gene expression in several cell types. To determine whether PKC mediates AA-stimulated MKP-1 induction in VSMCs, PKC was either depleted by exposing VSMCs to 1 μm PMA for 24 h or inhibited by incubating the cells with calphostin C before AA stimulation. PMA pretreatment did not reduce MKP-1 or mRNA levels but enhanced the induction by AA (Fig.4). Similar findings were obtained with the PKC specific inhibitor, calphostin C, i.e. no significant inhibition of AA-induced expression (Fig. 4). Together, these results indicate that the AA-stimulated MKP-1 induction is independent of PKC. Because it has been demonstrated that AA stimulation results in superoxide generation, independent of PKC, in phagocytes (42Henderson L.M. Moule S.K. Chappell J.B. Eur. J. Biochem. 1993; 211: 157-162Crossref PubMed Scopus (77) Google Scholar, 43Sakata A. Ida E. Tominaga M. Onoue K. J. Immunol. 1987; 138: 4353-4359PubMed Google Scholar) and VSMCs (44Griendling K.K. Minieri C.A. Ollerenshaw J.D. Alexander R.W. Circ. Res. 1994; 74: 1141-1148Crossref PubMed Scopus (2377) Google Scholar), we assessed whether AA-induced MKP-1 expression was mediated by released free radicals via AA-activated NADPH oxidase. The antioxidant N-acetylcysteine, shown to be a superoxide anion scavenger, blocked H2O2-induced ERK activation in HeLa cells (45Guyton K.Z. Liu Y. Gorospe M. Xu Q. Holbrook N.J. J. Biol. Chem. 1996; 271: 4138-4142Abstract Full Text Full Text PDF PubMed Scopus (1138) Google Scholar). When N-acetylcysteine was added to the culture with adjusting pH of the medium, AA-stimulated MKP-1 production was inhibited in a dose-dependent manner (Fig.5). More than 50% of AA-stimulated protein induction was inhibited at a concentration of 40 mm(Fig. 5, A and B), whereas 20 mmabolished the MKP-1 mRNA induction by AA (Fig. 5, C andD). Moreover, VSMCs treated with H2O2 resulted in MKP-1 gene expression and MKP-1 induction in a dose-dependent manner (Fig.6), supporting the involvement of a redox mechanism of MKP-1 induction.Figure 6H2O2 stimulates MKP-1 induction. Panel A, Western blot analysis for the induction of MKP-1 by H2O2. After treatment with H2O2 in the indicated concentrations for 1 h, VSMCs were harvested for protein extracts and Western blot analysis as described under "Experimental Procedures." Panel B, Northern blot analysis for MKP-1 mRNA expression. Quiescent VSMCs were treated with H2O2 at 37 °C for 30 min and harvested for RNA isolation and Northern blot analysis as described in the legend to Fig. 2. The lower panel shows 28 S and 18 S RNA. AA, treated with arachidonic acid.View Large Image Figure ViewerDownload (PPT) Tyrosine kinases have been shown to be involved in several signal transduction pathways such as growth factor-ras-MAPKs and G-protein-dependent pathways (46Wan Y. Kurosaki T. Huang X.Y. Nature. 1996; 380: 541-544Crossref PubMed Scopus (258) Google Scholar, 47Tokiwa G. Dikic I. Lev S. Schlessinger J. Science. 1996; 273: 792-794Crossref PubMed Scopus (285) Google Scholar). Therefore, we pretreated VSMCs with genistein or herbimycin A to inhibit different types of tyrosine kinases. As shown in Fig.7, genistein treatment completely blocked AA-stimulated MKP-1 induction of both proteins and mRNA in VSMCs, whereas herbimycin A had a moderate influence in this induction (Fig.7). In addition, genistein alone stimulated a modicum of MKP-1 mRNA induction in VSMCs (Fig. 7 D), although the mechanism of this induction remains unknown. Our data support the involvement of genistein-sensitive tyrosine kinases in AA-induced MKP-1 expression. Both ERK and JNK/SAPK can be activated by AA (25Rao G.N. Baas A.S. Glasgow W.C. Eling T.E. Runge M.S. Alexander R.W. J. Biol. Chem. 1994; 269: 32586-32591Abstract Full Text PDF PubMed Google Scholar, 26Hii C.S.T. Ferrante A. Edwards Y.S. Huang Z.H. Hartfield P.J. Rathjen D.A. Poulos A. Murray A.W. J. Biol. Chem. 1995; 270: 4201-4204Abstract Full Text Full Text PDF PubMed Scopus (106) Google Scholar, 27Cui X.L. Douglas J.G. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 3771-3776Crossref PubMed Scopus (163) Google Scholar), and MKP-1 induction was demonstrated to be dependent on JNK/SAPK and/or ERK cascades (48Bokemeyer D. Sorokin A. Yan M. Ahn N.G. Templeton D.J. Dunn M.J. J. Biol. Chem. 1996; 271: 639-642Abstract Full Text Full Text PDF PubMed Scopus (153) Google Scholar, 49Brondello J.M. Brunet A. Pouyssegur J. McKenzie F.R. J. Biol. Chem. 1997; 272: 1368-1376Crossref PubMed Scopus (317) Google Scholar). To investigate whether these kinases are involved in AA-induced MKP-1 expression, ERK activities and MKP-1 induction were determined simultaneously in VSMCs pretreated with PD 98059, a specific MAPK kinase (MEK1/2) inhibitor. A marked activation o

MAPK activity and MAP kinase phosphatase 2 (AtMKP2) protein stability under altered glutathione homeostasis in

Regulation of GCL Activity and Cellular Glutathione Through Inhibition of ERK Phosphorylation

Abstract 4061: Depleting the cellular level of glutathione and subsequently<i>S</i>-glutathionylation of keap1 by electrophilic agents activates keap1-nrf2 pathway

Distinct regulation of salinity and genotoxic stress responses by Arabidopsis MAP kinase phosphatase 1

Knockout of AtMKK1 Enhances Salt Tolerance and Modifies Metabolic Activities in Arabidopsis.

Chemical-sensitized MITOGEN-ACTIVATED PROTEIN KINASE 4 provides insights into its functions in plant growth and immunity

MAP kinase phosphatase 1 harbors a novel PTS1 and is targeted to peroxisomes following stress treatments

Glutathione S-Transferase P Elicits Protection Against H2o2-Induced Cell Death Via Coordinated Regulation of Stress Kinases

Crystal structure of plant γ-glutamyl peptidase 1 with dual roles in sulfur metabolism and implications for oxidative stress regulation

[YIA] IDENTIFICATION OF INTRAMEMBRANE PROTEASES THAT ACTIVATE MEMBRANE-BOUND TRANSCRIPTION FACTORS DURING MITOCHONDRIAL RETROGRADE REGULATION

Phosphorylation of Arabidopsis MAP Kinase Phosphatase 1 (MKP1) is Required for PAMP Responses and Resistance Against Bacteria

A Redox-Sensitive Cysteine Residue Regulates the Kinase Activities of OsMPK3 and OsMPK6 in Vitro

The Role of Nuclear Factor E2-Related Factor 2 and Uncoupling Protein 2 in Glutathione Metabolism: Evidence from an in Vivo Gene Knockout Study

Characterization of Xi-class Mycothiol S-transferase from Corynebacterium Glutamicum and Its Protective Effects in Oxidative Stress

Mitogen-Activated Protein Kinase Phosphatase-1: A Critical Phosphatase Manipulating Mitogen-Activated Protein Kinase Signaling In Cardiovascular Disease

Novel Role for Glutathione S-Transferase Π

The tomato mitogen-activated protein kinase SlMPK1 is as a negative regulator of the high temperature stress response.

The MAP kinase substrate MKS1 is a regulator of plant defense responses

Regulation of Innate and Adaptive Immune Responses by MAP Kinase Phosphatase 5

Crystal Structure of the Phosphorylated Arabidopsis MKK5 Reveals Activation Mechanism of MAPK Kinases

Induction of Mitogen-activated Protein Kinase Phosphatase-1 by Arachidonic Acid in Vascular Smooth Muscle Cells